According to Astellas Pharma's latest financial reports the company's current earnings (TTM) are HK$1.25 B. In 2023 the company made an earning of HK$0.95 B a decrease over its 2022 earnings that were of HK$9.48 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.